ArticlePloS one2014

A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cells.

Mei Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.